Jefferies downgrades Pacira Pharmaceuticals stock rating on Viatris deal

Markets Investing.com By Investing.com 08 Oct 2026 17:25 1 min read
Jefferies downgrades Pacira Pharmaceuticals stock rating on Viatris deal

Covered in this story

What has happened since

  • Viatris is up 1.1% since this was published.

Price move measured from the close nearest publication to the latest quote.

Call it yourself

No calls on $VTRS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Viatris →
Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.